BAT1706 injection

BIOLOGICAL2 trials

Sponsors

Bio-Thera Solutions

Conditions

Healthy MenNSCLC

Phase 1

Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects

CompletedNCT03030430

Bio-Thera SolutionsNSCLC

Start: 2016-03-15End: 2017-06-28Updated: 2018-07-30

A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection

Bio-Thera SolutionsHealthy Men

Start: 2023-06-30End: 2024-01-31Target: 38Updated: 2023-05-19

Related Papers

A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin<sup>®</sup>) in Healthy Male Subjects.

2019-06-0110 citations